Manufacturing
-
CPC Fluid Connectors - We're Your Army
5/17/2019
CPC has an army of biopharma experts ready to provide you with highly-tested bio-pharma connectors and global support.
-
Early Development Choices Define Scalability And Product Quality In CGT
10/29/2025
In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene stress that early-stage process decisions have lasting downstream effects on product quality, scalability, and speed to clinic.
-
A Transformative Journey From Research To Large-Scale Production
11/16/2023
Learn about MilliporeSigma's journey to becoming a leader in clinical and commercial viral vector manufacturing and their support of cell and gene therapy innovators since the industry’s beginnings.
-
Leveraging Single-Use Bioreactors In Bench-Scale Process Development
11/6/2025
Scaling bioprocesses requires matching critical variables to ensure consistent cell behavior and product quality. Optimize operations with efficient tools that enable more experiments per year.
-
QC Sampling Post-Thaw And Scaling Up Automated Processes For iPSCs
4/15/2025
During this portion of our Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists, Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio continue the discussion on post-thaw processing, focusing on QC sampling and the challenges of scaling up automated thawing.
-
Freezing Studies For Single-Use Solutions: Therapy Containment/Protection (Part 3)
5/14/2024
Watch part 3 of a four-part series, "Four Common Types Of Cryogenic Studies For Advanced Therapies," to learn about therapy containment/protection studies.
-
Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders
10/23/2022
Learn how government leaders in Saudi Arabia planned for biopharma resilience beyond borders and used agile manufacturing to prepare for the unknown.
-
How Automation Drives Down Cell Therapy Manufacturing Costs
2/26/2021
In this webinar segment, Dr. Mark Gilbert, Thomas Lequertier, and Luděk Sojka discussed how automation drives down manufacturing costs and the long road ahead to achieve continuous improvement.
-
The Importance Of Early Manufacturing Choices And Simple Flexible Process Design
10/29/2025
In this first segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene explore how early manufacturing decisions influence long-term success in cell therapy development.
-
DNA Sizing Data & Quantifying Residual HEK293 Host Cell DNA
1/26/2023
Learn about key considerations for measuring HEK293 DNA in your cell and gene therapy products and how you can perform residual DNA sizing and quantification with a single instrument.